4-Methyl-2-phenylpent-2-enal
Common Name: |
4-Methyl-2-phenylpent-2-enal |
IUPAC Name: |
(E)-4-methyl-2-phenylpent-2-enal |
Molecular Formula: |
C12H14O |
SMILES: |
CC(C)C=C(C=O)C1=CC=CC=C1 |
Inchi: |
1S/C12H14O/c1-10(2)8-12(9-13)11-6-4-3-5-7-11/h3-10H,1-2H3/b12-8- |
Inchi Key: |
ULRYRAHIBWLZKC-WQLSENKSSA-N |
Cas No: |
26643-91-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
174.24 |
Mass (g/mol) |
174.104 |
Molar Refractivity |
55.96 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
265.00 to 266.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.01 |
Vapor Density (Air =1) |
6 |
Fraction Csp3 |
0.25 |
LogP |
2.925 |
iLOGP |
2.27 |
XLOGP3 |
2.95 |
WLOGP |
2.92 |
MLOGP |
2.89 |
ESOL Log S |
-2.92 |
ESOL Solubility (mg/ml) |
0.208 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.97 |
Ali Solubility (mg/ml) |
0.19 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.25 |
Silicos-IT Solubility (mg/ml) |
0.1 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.27 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.708 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.824 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |